基于5年临床随访数据构建结直肠癌的预后预测模型
Boao Xiao1,2, Min Yang1,2, Yao Meng1,2
1School of Public Health, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, China.
Scientific reports
|January 21, 2025
概括
一个新的机器学习模型使用临床数据准确预测结直肠癌 (CRC) 患者的预后. 该工具可以识别高风险个体,帮助制定个性化治疗策略,以获得更好的结果.
科学领域:
- 在瘤学瘤学.
- 医疗信息学 医疗信息学
- 机器学习 机器学习
背景情况:
- 结肠直肠癌 (CRC) 是一个重大的公共卫生挑战.
- 准确的预后预测对于有效的患者管理和治疗计划至关重要.
研究的目的:
- 开发和验证用于预测结直肠癌患者预后的机器学习模型.
- 确定与CRC患者预后不佳相关的关键临床变量.
主要方法:
- 利用了411名结肠直肠癌患者的数据集,以及五年的随访数据.
- 采用递归特征消除 (RFE) 来选择决策树,随机森林,支持矢量机和极端梯度增强 (XGBoost) 模型的特征.
- 使用网格搜索优化超参数,并通过多个指标评估模型性能,包括精度,F1得分和ROC曲线.
- 使用夏普利添加式扩展 (SHAP) 解释了最佳模型.
主要成果:
- 该RFE-XGBoost模型实现了高性能:0.83准确度,0.81F1得分和0.89AUC.
- 该模型展示了优越的校准和临床实用性.
- SHAP分析确定了术后输血,AJCC阶段,CEA,CA19-9,年龄和CA125作为死亡风险的重要预测因素.
结论:
- 该RFE-XGBoost模型有效预测结直肠癌患者的预后.
- SHAP分析提高了预测模型的可解释性和临床可信度.
- 这种方法为识别高风险CRC患者提供了有价值的工具,有可能改善临床决策.
相关概念视频
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


